TDZD-8 (TDZD8, TDZD 8, NP 01139, NP-01139, NP01139) 是一种高效的、非ATP竞争性的GSK-3β抑制剂，其IC50值为2 μM，对Cdk-1、CK-II、PKA和PKC的抑制效果最小。TDZD-8可以降低神经元坏死和神经胶质细胞凋亡水平，并有一定程度的抗白血病活性。

参考文献

[1]. Nasim S, et al. Discovery of 1,2,4-thiadiazolidine-3,5-dione analogs that exhibit unusual and selective rapid cell death kinetics against acute myelogenous leukemia cells in culture. Bioorg Med Chem Lett. 2011 Aug 15;21(16):4879-83.

[2]. Zhao J, et al. Lupus nephritis: glycogen synthase kinase 3β promotion of renal damage through activation of the NLRP3 inflammasome in lupus-prone mice. Arthritis Rheumatol. 2015 Apr;67(4):1036-44.

冰袋运输。粉末直接保存于-20℃，有效期2年。溶于DMSO。建议分装后-20℃避光保存，避免反复冻融。